J Reconstr Microsurg
DOI: 10.1055/a-2331-7885
Original Article

Optimizing Surgical Outcomes and the Role of Preventive Surgery: A Scoping Review

1   Department of Surgery, Division of Plastic and Reconstructive Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
,
Benjamin Rahmani
1   Department of Surgery, Division of Plastic and Reconstructive Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
,
Oluwaseun D. Adebagbo
1   Department of Surgery, Division of Plastic and Reconstructive Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
2   Department of Surgery, Tufts University School of Medicine, Boston, Massachusetts
,
John Park
1   Department of Surgery, Division of Plastic and Reconstructive Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
,
Shannon R. Garvey
1   Department of Surgery, Division of Plastic and Reconstructive Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
,
Amy Chen
1   Department of Surgery, Division of Plastic and Reconstructive Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
,
Sasha Nickman
1   Department of Surgery, Division of Plastic and Reconstructive Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
,
Micaela Tobin
1   Department of Surgery, Division of Plastic and Reconstructive Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
,
Lauren Valentine
1   Department of Surgery, Division of Plastic and Reconstructive Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
,
Allan A. Weidman
1   Department of Surgery, Division of Plastic and Reconstructive Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
,
Dhruv Singhal
1   Department of Surgery, Division of Plastic and Reconstructive Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
,
Arriyan Dowlatshahi
1   Department of Surgery, Division of Plastic and Reconstructive Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
,
Samuel J. Lin
1   Department of Surgery, Division of Plastic and Reconstructive Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
,
Bernard T. Lee
1   Department of Surgery, Division of Plastic and Reconstructive Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
› Author Affiliations
Funding This study was supported by the Tufts University School of Medicine; the National Center for Advancing Translational Sciences, National Institutes of Health (T32TR004417).

Abstract

Background Plastic and reconstructive surgeons are often presented with reconstructive challenges as a sequela of complications in high-risk surgical patients, ranging from exposure of hardware, lymphedema, and chronic pain after amputation. These complications can result in significant morbidity, recovery time, resource utilization, and cost. Given the prevalence of surgical complications managed by plastic and reconstructive surgeons, developing novel preventative techniques to mitigate surgical risk is paramount.

Methods Herein, we aim to understand efforts supporting the nascent field of Preventive Surgery, including (1) enhanced risk stratification, (2) advancements in postoperative care. Through an emphasis on four surgical cohorts who may benefit from preventive surgery, two of which are at high risk of morbidity from wound-related complications (patients undergoing sternotomy and spine procedures) and two at high risk of other morbidities, including lymphedema and neuropathic pain, we aim to provide a comprehensive and improved understanding of preventive surgery. Additionally, the role of risk analysis for these procedures and the relationship between microsurgery and prophylaxis is emphasized.

Results (1) medical optimization and prehabilitation, (2) surgical mitigation techniques.

Conclusion Reconstructive surgeons are ideally placed to lead efforts in the creation and validation of accurate risk assessment tools and to support algorithmic approaches to surgical risk mitigation. Through a paradigm shift, including universal promotion of the concept of “Preventive Surgery,” major improvements in surgical outcomes may be achieved.

Ethical Approval

Not required.




Publication History

Received: 13 March 2024

Accepted: 22 May 2024

Accepted Manuscript online:
23 May 2024

Article published online:
18 June 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Harrison B, Khansa I, Janis JE. Evidence-based strategies to reduce postoperative complications in plastic surgery. Plast Reconstr Surg 2016; 138 (03) 51S-60S
  • 2 Erba P, Ogawa R, Vyas R, Orgill DP. The reconstructive matrix: a new paradigm in reconstructive plastic surgery. Plast Reconstr Surg 2010; 126 (02) 492-498
  • 3 An Ounce of Prevention Is Worth a Pound of Cure. Merriam-Webster.com. Accessed May 29, 2024 at: https://www.merriam-webster.com/dictionary/an%20ounce%20of%20prevention%20is%20worth%20a%20pound%20of%20cure
  • 4 American College of Preventive Medicine. About ACPM: Mission & History. Accessed May 29, 2024 at: https://www.acpm.org/about-acpm/mission-history/
  • 5 Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40 (05) 373-383
  • 6 Golas AR, Boyko T, Schwartz TH, Stieg PE, Boockvar JA, Spector JA. Prophylactic plastic surgery closure of neurosurgical scalp incisions reduces the incidence of wound complications in previously-operated patients treated with bevacizumab (Avastin®) and radiation. J Neurooncol 2014; 119 (02) 327-331
  • 7 Fischer JP, Nelson JA, Rohrbach JI. et al. Prophylactic muscle flaps in vascular surgery: the Penn Groin Assessment Scale. Plast Reconstr Surg 2012; 129 (06) 940e-949e
  • 8 Cauley RP, Slatnick BL, Truche P. et al. Development of a risk score to predict occurrence of deep sternal dehiscence requiring operative debridement. J Thorac Cardiovasc Surg 2024; 167 (02) 757-764.e8
  • 9 Nelson JA, Chung CU, Fischer JP, Kanchwala SK, Serletti JM, Wu LC. Wound healing complications after autologous breast reconstruction: a model to predict risk. J Plast Reconstr Aesthet Surg 2015; 68 (04) 531-539
  • 10 Bilimoria KY, Liu Y, Paruch JL. et al. Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. J Am Coll Surg 2013; 217 (05) 833-42.e1 , 3
  • 11 Stone R, Carey E, Fader AN. et al. Enhanced recovery and surgical optimization protocol for minimally invasive gynecologic surgery: an AAGL white paper. J Minim Invasive Gynecol 2021; 28 (02) 179-203
  • 12 Møller AM, Villebro N, Pedersen T, Tønnesen H. Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet 2002; 359 (9301) 114-117
  • 13 Punnoose A, Claydon-Mueller LS, Weiss O, Zhang J, Rushton A, Khanduja V. Prehabilitation for patients undergoing orthopedic surgery: a systematic review and meta-analysis. JAMA Netw Open 2023; 6 (04) e238050
  • 14 Benck KN, Alnajar A, Lamelas J. Impact of bariatric surgery on mortality of mitral valve surgery: a national analysis. Innovations (Phila) 2023; 18 (06) 540-546
  • 15 Tsilingiris D, Kokkinos A. Advances in obesity pharmacotherapy; learning from metabolic surgery and beyond. Metabolism 2024; 151: 155741
  • 16 Han SH, Safeek R, Ockerman K. et al. Public interest in the off-label use of glucagon-like peptide 1 agonists (Ozempic) for cosmetic weight loss: a google trends analysis. Aesthet Surg J 2023; 44 (01) 60-67
  • 17 Nooh E, Griesbach C, Rösch J, Weyand M, Harig F. Development of a new sternal dehiscence prediction scale for decision making in sternal closure techniques after cardiac surgery. J Cardiothorac Surg 2021; 16 (01) 174
  • 18 Robicsek F, Fokin A, Cook J, Bhatia D. Sternal instability after midline sternotomy. Thorac Cardiovasc Surg 2000; 48 (01) 1-8
  • 19 Filsoufi F, Castillo JG, Rahmanian PB. et al. Epidemiology of deep sternal wound infection in cardiac surgery. J Cardiothorac Vasc Anesth 2009; 23 (04) 488-494
  • 20 Allen KB, Thourani VH, Naka Y. et al. Randomized, multicenter trial comparing sternotomy closure with rigid plate fixation to wire cerclage. J Thorac Cardiovasc Surg 2017; 153 (04) 888-896.e1
  • 21 Song DH, Lohman RF, Renucci JD, Jeevanandam V, Raman J. Primary sternal plating in high-risk patients prevents mediastinitis. Eur J Cardiothorac Surg 2004; 26 (02) 367-372
  • 22 Neaman KC, Blount AL, Kim JA, Renucci JD, Hooker RL. Prophylactic sternal plating with pectoralis advancement flaps after sternotomy in patients with a history of chest irradiation. Interact Cardiovasc Thorac Surg 2011; 12 (03) 355-358
  • 23 Allen KB, Icke KJ, Thourani VH. et al. Sternotomy closure using rigid plate fixation: a paradigm shift from wire cerclage. Ann Cardiothorac Surg 2018; 7 (05) 611-620
  • 24 Chen A, Garvey SR, Adebagbo O. et al. Novel use of interosseous absorbable mattress sutures for secondary sternal fixation: a case series. J Plast Reconstr Aesthet Surg 2023; 87: 387-389
  • 25 Sloan R, Elliott RJ. A kinetic assay for the isoenzymes of malate dehydrogenase. Biochem Soc Trans 1991; 19 (01) 54S
  • 26 Piper KF, Tomlinson SB, Santangelo G. et al. Risk factors for wound complications following spine surgery. Surg Neurol Int 2017; 8: 269
  • 27 Cohen LE, Fullerton N, Mundy LR. et al. Optimizing successful outcomes in complex spine reconstruction using local muscle flaps. Plast Reconstr Surg 2016; 137 (01) 295-301
  • 28 Akins PT, Harris J, Alvarez JL. et al. Risk factors associated with 30-day readmissions after instrumented spine surgery in 14,939 patients: 30-day readmissions after instrumented spine surgery. Spine 2015; 40 (13) 1022-1032
  • 29 McCormack RA, Hunter T, Ramos N, Michels R, Hutzler L, Bosco JA. An analysis of causes of readmission after spine surgery. Spine 2012; 37 (14) 1260-1266
  • 30 De la Garza-Ramos R, Abt NB, Kerezoudis P. et al. Deep-wound and organ-space infection after surgery for degenerative spine disease: an analysis from 2006 to 2012. Neurol Res 2016; 38 (02) 117-123
  • 31 Schweizer ML, Cullen JJ, Perencevich EN, Vaughan Sarrazin MS. Costs associated with surgical site infections in veterans affairs hospitals. JAMA Surg 2014; 149 (06) 575-581
  • 32 Kuhns BD, Lubelski D, Alvin MD. et al. Cost and quality of life outcome analysis of postoperative infections after subaxial dorsal cervical fusions. J Neurosurg Spine 2015; 22 (04) 381-386
  • 33 Dalton T, Darner G, McCray E. et al. Prophylactic muscle flaps decrease wound complication rates in patients with oncologic spine disease. Plast Reconstr Surg 2024; 153 (01) 221-231
  • 34 Hegde V, Meredith DS, Kepler CK, Huang RC. Management of postoperative spinal infections. World J Orthop 2012; 3 (11) 182-189
  • 35 Meredith DS, Kepler CK, Huang RC, Brause BD, Boachie-Adjei O. Postoperative infections of the lumbar spine: presentation and management. Int Orthop 2012; 36 (02) 439-444
  • 36 Manstein ME, Manstein CH, Manstein G. Paraspinous muscle flaps. Ann Plast Surg 1998; 40 (05) 458-462
  • 37 Houten JK, Weinstein GR, Collins MJ, Komlos D. Bilateral paraspinal muscle flap closure technique for reduction of wound complications from posterior thoracolumbar spinal fusion: results of a series of 716 patients. J Neurosurg Spine 2020; 34 (02) 211-217
  • 38 Mericli AF, Largo RD, Garvey PB. et al. Immediate reconstruction of complex spinal wounds is associated with increased hardware retention and fewer wound-related complications: a systematic review and meta-analysis. Plast Reconstr Surg Glob Open 2019; 7 (01) e2076
  • 39 Price MJ, Tillis R, Howell EP. et al. Muscle flap closures in spine surgery: predictors of usage patterns and factors associated with postoperative complications from the NSQIP database. Clin Spine Surg 2022; 35 (01) E248-E258
  • 40 Ziegler-Graham K, MacKenzie EJ, Ephraim PL, Travison TG, Brookmeyer R. Estimating the prevalence of limb loss in the United States: 2005 to 2050. Arch Phys Med Rehabil 2008; 89 (03) 422-429
  • 41 McNamara CT, Iorio ML. Targeted muscle reinnervation: outcomes in treating chronic pain secondary to extremity amputation and phantom limb syndrome. J Reconstr Microsurg 2020; 36 (04) 235-240
  • 42 Arnold DMJ, Wilkens SC, Coert JH, Chen NC, Ducic I, Eberlin KR. Diagnostic criteria for symptomatic neuroma. Ann Plast Surg 2019; 82 (04) 420-427
  • 43 Bergmeister KD, Große-Hartlage L, Daeschler SC. et al. Acute and long-term costs of 268 peripheral nerve injuries in the upper extremity. PLoS One 2020; 15 (04) e0229530
  • 44 Menorca RM, Fussell TS, Elfar JC. Nerve physiology: mechanisms of injury and recovery. Hand Clin 2013; 29 (03) 317-330
  • 45 Limakatso K, Bedwell GJ, Madden VJ, Parker R. The prevalence and risk factors for phantom limb pain in people with amputations: a systematic review and meta-analysis. PLoS One 2020; 15 (10) e0240431
  • 46 Zamore Z, Yesantharao PS, Aravind P, Dellon AL. Economic cost-benefit analysis of nerve implanted into muscle versus targeted muscle reinnervation versus regenerative peripheral nerve interface, for treatment of the painful neuroma. . J Reconstr Microsurg 2024
  • 47 Deeyor ST, Kisana HM, Hui CH, Stecher C, Hustedt JW. Targeted muscle reinnervation does not increase the risk of postsurgical complication or overall cost. Plast Reconstr Surg Glob Open 2022; 10 (08) e4488
  • 48 Kuiken TA, Barlow AK, Hargrove L, Dumanian GA. Targeted muscle reinnervation for the upper and lower extremity. Tech Orthop 2017; 32 (02) 109-116
  • 49 Ives GC, Kung TA, Nghiem BT. et al. Current state of the surgical treatment of terminal neuromas. Neurosurgery 2018; 83 (03) 354-364
  • 50 Chang BL, Mondshine J, Attinger CE, Kleiber GM. Targeted muscle reinnervation improves pain and ambulation outcomes in highly comorbid amputees. Plast Reconstr Surg 2021; 148 (02) 376-386
  • 51 Dumanian GA, Potter BK, Mioton LM. et al. Targeted muscle reinnervation treats neuroma and phantom pain in major limb amputees: a randomized clinical trial. Ann Surg 2019; 270 (02) 238-246
  • 52 Salminger S, Sturma A, Roche AD, Mayer JA, Gstoettner C, Aszmann OC. Outcomes, challenges, and pitfalls after targeted muscle reinnervation in high-level amputees: is it worth the effort?. Plast Reconstr Surg 2019; 144 (06) 1037e-1043e
  • 53 Hooper RC, Cederna PS, Brown DL. et al. Regenerative peripheral nerve interfaces for the management of symptomatic hand and digital neuromas. Plast Reconstr Surg Glob Open 2020; 8 (06) e2792
  • 54 Kung TA, Bueno RA, Alkhalefah GK, Langhals NB, Urbanchek MG, Cederna PS. Innovations in prosthetic interfaces for the upper extremity. Plast Reconstr Surg 2013; 132 (06) 1515-1523
  • 55 Goodyear EG, O'Brien AL, West JM. et al. Targeted muscle reinnervation at the time of amputation decreases recurrent symptomatic neuroma formation. Plast Reconstr Surg 2024; 153 (01) 154-163
  • 56 Kurlander DE, Wee C, Chepla KJ. et al. TMRpni: combining two peripheral nerve management techniques. Plast Reconstr Surg Glob Open 2020; 8 (10) e3132
  • 57 Mauch JT, Kao DS, Friedly JL, Liu Y. Targeted muscle reinnervation and regenerative peripheral nerve interfaces for pain prophylaxis and treatment: a systematic review. PM R 2023; 15 (11) 1457-1465
  • 58 Felder JM, Pripotnev S, Ducic I, Skladman R, Ha AY, Pet MA. Failed targeted muscle reinnervation: findings at revision surgery and concepts for success. Plast Reconstr Surg Glob Open 2022; 10 (04) e4229
  • 59 Deldar R, Spoer D, Gupta N. et al. Prophylactic lymphovenous bypass at the time of axillary lymph node dissection decreases rates of lymphedema. Ann Surg Open 2023; 4 (02) e278
  • 60 Fu MR, Kang Y. Psychosocial impact of living with cancer-related lymphedema. Semin Oncol Nurs 2013; 29 (01) 50-60
  • 61 DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 2013; 14 (06) 500-515
  • 62 Agarwal S, Garza RM, Chang DW. Lymphatic microsurgical preventive healing approach (LYMPHA) for the prevention of secondary lymphedema. Breast J 2020; 26 (04) 721-724
  • 63 Gillespie TC, Sayegh HE, Brunelle CL, Daniell KM, Taghian AG. Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments. Gland Surg 2018; 7 (04) 379-403
  • 64 Basta MN, Fox JP, Kanchwala SK. et al. Complicated breast cancer-related lymphedema: evaluating health care resource utilization and associated costs of management. Am J Surg 2016; 211 (01) 133-141
  • 65 Lipman K, Luan A, Stone K, Wapnir I, Karin M, Nguyen D. Lymphatic microsurgical preventive healing approach (LYMPHA) for lymphedema prevention after axillary lymph node dissection-a single institution experience and feasibility of technique. J Clin Med 2021; 11 (01) 92
  • 66 Shih YC, Xu Y, Cormier JN. et al. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol 2009; 27 (12) 2007-2014
  • 67 Allam O, Park KE, Chandler L. et al. The impact of radiation on lymphedema: a review of the literature. Gland Surg 2020; 9 (02) 596-602
  • 68 Basta MN, Wu LC, Kanchwala SK. et al. Reliable prediction of postmastectomy lymphedema: the risk assessment tool evaluating lymphedema. Am J Surg 2017; 213 (06) 1125-1133.e1
  • 69 Granoff MD, Pardo JA, Johnson AR. et al. Superficial and functional lymphatic anatomy of the upper extremity. Plast Reconstr Surg 2022; 150 (04) 900-907
  • 70 Li F, Lu Q, Jin S. et al. A scoring system for predicting the risk of breast cancer-related lymphedema. Int J Nurs Sci 2019; 7 (01) 21-28
  • 71 Brunelle C, Skolny M, Ferguson C, Swaroop M, O'Toole J, Taghian AG. Establishing and sustaining a prospective screening program for breast cancer-related lymphedema at the Massachusetts General Hospital: lessons learned. J Pers Med 2015; 5 (02) 153-164
  • 72 Akita S, Nakamura R, Yamamoto N. et al. Early detection of lymphatic disorder and treatment for lymphedema following breast cancer. Plast Reconstr Surg 2016; 138 (02) 192e-202e
  • 73 Boccardo F, Casabona F, De Cian F. et al. Lymphedema microsurgical preventive healing approach: a new technique for primary prevention of arm lymphedema after mastectomy. Ann Surg Oncol 2009; 16 (03) 703-708
  • 74 Boccardo F, Casabona F, De Cian F. et al. Lymphatic microsurgical preventing healing approach (LYMPHA) for primary surgical prevention of breast cancer-related lymphedema: over 4 years follow-up. Microsurgery 2014; 34 (06) 421-424
  • 75 Johnson AR, Singhal D. Immediate lymphatic reconstruction. J Surg Oncol 2018; 118 (05) 750-757
  • 76 Hill WKF, Deban M, Platt A, Rojas-Garcia P, Jost E, Temple-Oberle C. Immediate lymphatic reconstruction during axillary node dissection for breast cancer: a systematic review and meta-analysis. Plast Reconstr Surg Glob Open 2022; 10 (05) e4291
  • 77 Lin YS, Kuan CH, Lo C. et al. Is immediate lymphatic reconstruction on breast cancer patients oncologically safe? A preliminary study. Plast Reconstr Surg Glob Open 2023; 11 (11) e5385
  • 78 Reddy S, Khalifian S, Flores JM. et al. Clinical outcomes in cranioplasty: risk factors and choice of reconstructive material. Plast Reconstr Surg 2014; 133 (04) 864-873
  • 79 Garvey SR, Filippidis AS, Chen A, Gettings ML, Vega RA, Cauley RP. Double cranial stair-step incision: a method for prophylactic closure of high-risk neurosurgical procedures. J Plast Reconstr Aesthet Surg 2023; 87: 210-212
  • 80 Chiang HY, Kamath AS, Pottinger JM. et al. Risk factors and outcomes associated with surgical site infections after craniotomy or craniectomy. J Neurosurg 2014; 120 (02) 509-521
  • 81 Wallace AB, Piper ML, Holland M. et al. Prophylactic muscle flaps in primary vascular procedures of the groin. Ann Vasc Surg 2022; 78: 77-83
  • 82 Sandmann W. How to avoid lymphatic wound complications after vascular groin surgery. Eur J Vasc Endovasc Surg 2016; 52 (02) 263
  • 83 Fischer JP, Nelson JA, Mirzabeigi MN. et al. Prophylactic muscle flaps in vascular surgery. J Vasc Surg 2012; 55 (04) 1081-1086
  • 84 Blok RD, de Jonge J, de Koning MA. et al. Propensity score adjusted comparison of pelviperineal morbidity with and without omentoplasty following abdominoperineal resection for primary rectal cancer. Dis Colon Rectum 2019; 62 (08) 952-959
  • 85 Sayers AE, Patel RK, Hunter IA. Perineal hernia formation following extralevator abdominoperineal excision. Colorectal Dis 2015; 17 (04) 351-355
  • 86 Orgill DP, Bayer LR. Update on negative-pressure wound therapy. Plast Reconstr Surg 2011; 127 (Suppl. 01) 105S-115S
  • 87 Sisco M, Kuchta K, Alva D, Seth AK. Oral antibiotics do not prevent infection or implant loss after immediate prosthetic breast reconstruction. Plast Reconstr Surg 2023; 151 (05) 730e-738e
  • 88 Kosins AM, Scholz T, Cetinkaya M, Evans GRD. Evidence-based value of subcutaneous surgical wound drainage: the largest systematic review and meta-analysis. Plast Reconstr Surg 2013; 132 (02) 443-450
  • 89 Cauley RP, Barron S, Slatnick B. et al. An algorithmic approach to the surgical management of sternal dehiscence: a single-center experience. J Reconstr Microsurg 2022; 38 (08) 671-682
  • 90 Friberg O, Dahlin LG, Levin LA. et al. Cost effectiveness of local collagen-gentamicin as prophylaxis for sternal wound infections in different risk groups. Scand Cardiovasc J 2006; 40 (02) 117-125
  • 91 Nguyen MH, Patel K, West J. et al. A multidisciplinary approach to complex oncological spine coverage in high-risk patients. J Neurosurg Spine 2020; 34 (02) 277-282
  • 92 Bloom JA, Tian T, Homsy C, Singhal D, Salehi P, Chatterjee A. A cost-utility analysis of the use of closed-incision negative pressure system in vascular surgery groin incisions. Am Surg 2023; 89 (06) 2237-2246
  • 93 Bloom JA, Granoff M, Karlsson T. et al. Power-assisted liposuction for lymphedema: a cost-utility analysis. Plast Reconstr Surg Glob Open 2022; 10 (11) e4671